TY  - JOUR
AU  - Gomez-Millan, J
AU  - Pajares, B
AU  - Perez-Villa, L
AU  - Carnero, A
AU  - Alvarez, M
AU  - De Luque, V
AU  - Rivas, F
AU  - Trigo, J M
AU  - Toledo, M D
AU  - Alba, E
AU  - Medina, J A
PY  - 2016
DO  - 10.1186/s12885-016-2869-x
UR  - http://hdl.handle.net/10668/10564
T2  - BMC cancer
AB  - MEK1 (MAP2K1) and MEK2 (MAP2K2) are closely related dual-specificity protein kinases which function by phosphorylating both serine/threonine and tyrosine residues of their substrates ERK1 and ERK2, controlling fundamental cellular processes that...
LA  - en
KW  - Head and neck cancer
KW  - Radiochemotherapy
KW  - pMEK
KW  - Adult
KW  - Aged
KW  - Biomarkers
KW  - Chemoradiotherapy
KW  - Extracellular Signal-Regulated MAP Kinases
KW  - Female
KW  - Gene Expression
KW  - Head and Neck Neoplasms
KW  - Humans
KW  - Immunohistochemistry
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Phosphorylation
KW  - Prognosis
KW  - Protein Transport
KW  - Risk Factors
KW  - Signal Transduction
TI  - Subcellular localisation of pMEK has a different prognosis in locally advanced head and neck cancer treated with concomitant radiochemotherapy.
TY  - research article
VL  - 16
ER  -